Can a bile acid pill tame hepatitis c? new study tests higher doses
NCT ID NCT00200343
First seen Jan 10, 2026 · Last updated Jun 13, 2026 · Updated 23 times
Summary
This study tested whether taking a higher dose of ursodeoxycholic acid (UDCA), a bile acid medication, could better control liver damage in people with chronic hepatitis C. About 596 adults in Japan took either 150 mg, 600 mg, or 900 mg of UDCA daily for 24 weeks. The main goal was to see if higher doses improved liver enzyme levels more than the low dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS C are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Gastroenterology, University of Tokyo
Hongo, Bunkyo-ku, Tokyo, Japan
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.